Image de couverture de livre

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Abel Tesfai, Natalia Norori, Thomas A. Harding, Yui Hang Wong, Matthew David Hobbs
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	BJUI Compass
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
par: Thomas Philip Cahill, et autres
Publié: (2024)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
par: Jeremy Cheng, et autres
Publié: (2025)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
par: Eric Margolis, et autres
Publié: (2025)

National survey of urologists' views on prostate cancer screening in the United Kingdom
par: Nikhil Mayor, et autres
Publié: (2026)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
par: Eric V. Li, et autres
Publié: (2024)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
par: Stijn M. van den Bosch, et autres
Publié: (2026)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
par: Esther H. J. Hamoen, et autres
Publié: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
par: Samantha Shekar, et autres
Publié: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
par: Muhammad Imran, et autres
Publié: (2026)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
par: Herbert Lepor, et autres
Publié: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
par: Alan Priester, et autres
Publié: (2024)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
par: Jennifer Dunsmore, et autres
Publié: (2024)

Emerging tools for the early detection of prostate cancer
par: Muhammad Haider, et autres
Publié: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
par: Sophia M. Abusamra, et autres
Publié: (2025)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
par: Jonathon Dawson, et autres
Publié: (2024)

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
par: See‐Tong Pang, et autres
Publié: (2025)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
par: Maxwell Louis Sandberg, et autres
Publié: (2026)

Bibliometric analysis of focal therapy in prostate cancer research
par: Mohammed Shahait, et autres
Publié: (2024)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
par: Nicole Handa, et autres
Publié: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
par: Mohammadmehdi Adhami, et autres
Publié: (2026)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
par: Muhammad Haider, et autres
Publié: (2025)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
par: Ailene E. Corona, et autres
Publié: (2026)

Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
par: Yuki Teramoto, et autres
Publié: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
par: Nadia Rokan, et autres
Publié: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
par: Ruth Pidsley, et autres
Publié: (2024)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
par: Angelo Porreca, et autres
Publié: (2025)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
par: Ryan Sutherland, et autres
Publié: (2024)

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
par: Laurence Klotz, et autres
Publié: (2024)

Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy
par: Georgios Daouacher, et autres
Publié: (2026)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
par: Geneva Pantoja, et autres
Publié: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
par: Sofia Mesquita, et autres
Publié: (2025)

The carbon footprint of transperineal prostate biopsy
par: Daniel A. Carson, et autres
Publié: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
par: Pierre Allainguillaume, et autres
Publié: (2026)

A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
par: Renil S. Titus, et autres
Publié: (2025)

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
par: Michela Roberto, et autres
Publié: (2025)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
par: Marcus Sondermann, et autres
Publié: (2025)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
par: Sandra Irenaeus, et autres
Publié: (2025)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
par: Austin Drysch, et autres
Publié: (2025)